Recent News

Connect with us

521 News Items found
Pictured: Alexander Rudensky
Profile
At Work: Immunologist Alexander Rudensky

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
In the News
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
Pictured: Joan Massagué
Announcement
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
The 1986 explosion at the Chernobyl nuclear power plant released radioactive particles in every direction.
In the Lab
Study Reveals Genetic Causes for Thyroid Cancer Increase after Chernobyl

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.
Pictured: Stephen Long & Alexandria Miller
Profile
At Work: Structural Biologist Stephen Long

Stephen Long works to understand how proteins work by determining what they look like in three dimensions.
Pictured: Craig Thompson
Event
Watch Webcast of “Major Trends” Seminar — Annual Event for High School Students

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Pictured: Emily Foley
Profile
At Work: Cell Biologist Emily Foley

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Breast cancer mosaic
Snapshot
New Technology Could Enable Immediate Detection of Tumor Borders during Surgery

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.